Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.
| Image |  |
|---|---|
| Description | scientific article published on 15 March 2018 |
| Author/s |
author: Darren R Feldman Toni K Choueiri Eric J Small Susan Halabi |
| Publication date | March 20, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |